NCT02660983View on ClinicalTrials.gov

A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

August 5, 2013

Primary Completion Date

July 13, 2018

Study Completion Date

December 21, 2018

Conditions
Dementia Associated With Cerebrovascular Disease
Interventions
DRUG

Donepezil hydrochloride

DRUG

Donepezil matching placebo

DRUG

Donepezil hydrochloride

Trial Locations (31)

Unknown

Daegu

Seongnam-si

Gwangju

Seoul

Seoul

Seoul

Chuncheon

Seoul

Anyang-si

Bucheon-si

Goyang-si

Seongnam-si

Suwon

Wonmi-gu

Changwon-si

Yangsan

Seoul

Daegu

Incheon

Seoul

Daegu

Incheon

Busan

Seoul

Seoul

Seoul

Seoul

Jongno-Gu

Seoul

Seoul

Seoul

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT02660983 - A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease | Biotech Hunter | Biotech Hunter